Ocrelizumab in Multiple Sclerosis: A Real-World Study From Spain

por Sempere, Angel P., Berenguer-Ruiz, Leticia, Borrego-Soriano, Ines, Burgos-San Jose, Amparo, Concepcion-Aramendia, Luis, Volar, Lucian, Aragones, Miguel, Palazón-Bru, Antonio
Publicado 2021

Deciphering Multiple Sclerosis Progression

por Meca-Lallana, Virginia, Berenguer-Ruiz, Leticia, Carreres-Polo, Joan, Eichau-Madueño, Sara, Ferrer-Lozano, Jaime, Forero, Lucía, Higueras, Yolanda, Téllez Lara, Nieves, Vidal-Jordana, Angela, Pérez-Miralles, Francisco Carlos
Publicado 2021

Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

por Fernandez‐Diaz, Eva, Perez‐Vicente, Jose A., Villaverde‐Gonzalez, Ramon, Berenguer‐Ruiz, Leticia, Candeliere Merlicco, Antonio, Martinez‐Navarro, Maria Luisa, Gracia Gil, Julia, Romero‐Sanchez, Carlos M., Alfaro‐Saez, Arantxa, Diaz, Inmaculada, Gimenez‐Martinez, Juana, Mendez‐Miralles, Maria Angeles, Millan‐Pascual, Jorge, Jimenez‐Pancho, Javier, Mola, Santiago, Sempere, Angel P.
Publicado 2020